Food and Drug Administration has specifically approved for weight loss, although you must meet certain criteria to get a prescription for them, such as a high body mass index (BMI)
Transparent Pricing All-inclusive - medicine, prescription, syringes, overnight shipping, and medical oversight
If you have questions about your medication's integrity after arrival, contact your PlexusDx provider or pharmacy immediately
Sources The New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity Zepbound Eli Lilly: Zepbound Coverage and Savings for Patients Zepbound Eli Lilly: Zepbound Coverage and Savings for Healthcare Providers Eli Lilly Investors: Lillys tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1 Eli Lilly Investors: Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers Important Current Status Update: On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide
Remember that your health and safety are the top priorities for both you and the donation center
